Us Physicalrapy Stock Analysis

USPH Stock  USD 77.34  0.34  0.44%   
US Physicalrapy is undervalued with Real Value of 87.65 and Target Price of 106.0. The main objective of US Physicalrapy stock analysis is to determine its intrinsic value, which is an estimate of what US Physicalrapy is worth, separate from its market price. There are two main types of US Physicalrapy's stock analysis: fundamental analysis and technical analysis.
The US Physicalrapy stock is traded in the USA on New York Stock Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and US Physicalrapy's ongoing operational relationships across important fundamental and technical indicators.
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in US Physicalrapy. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.
For more detail on how to invest in USPH Stock please use our How to Invest in US Physicalrapy guide.

USPH Stock Analysis Notes

About 98.0% of the company outstanding shares are owned by institutional investors. The book value of US Physicalrapy was at this time reported as 32.73. The company last dividend was issued on the 23rd of May 2025. US Physicalrapy had 3:2 split on the 29th of June 2001. Physical Therapy, Inc., through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. The company was founded in 1990 and is based in Houston, Texas. US Physical operates under Medical Care Facilities classification in the United States and is traded on New York Stock Exchange. It employs 3158 people. For more information please call Christopher Reading at 713 297 7000 or visit https://www.usph.com.

US Physicalrapy Quarterly Total Revenue

152.55 Million

US Physicalrapy Investment Alerts

Over 98.0% of the company outstanding shares are owned by institutional investors
On 13th of June 2025 US Physicalrapy paid $ 0.45 per share dividend to its current shareholders
Latest headline from gurufocus.com: U.S. Physical Therapy Presented at Investor Conferences

US Physicalrapy Upcoming and Recent Events

Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to US Physicalrapy previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
28th of February 2024
Upcoming Quarterly Report
View
1st of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
28th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

USPH Largest EPS Surprises

Earnings surprises can significantly impact US Physicalrapy's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2001-03-09
2000-12-310.090.10.0111 
1999-08-05
1999-06-300.050.060.0120 
1997-05-13
1997-03-310.030.040.0133 
View All Earnings Estimates

US Physicalrapy Environmental, Social, and Governance (ESG) Scores

US Physicalrapy's ESG score is a quantitative measure that evaluates US Physicalrapy's performance and commitment regarding environmental, social, and governance (ESG) factors. These scores are becoming increasingly crucial in investment decision-making processes, providing insights into non-financial aspects of US Physicalrapy's operations that may have significant financial implications and affect US Physicalrapy's stock price as well as guide investors towards more socially responsible investments.

USPH Stock Institutional Investors

Shares
Bahl & Gaynor Inc.2025-03-31
345 K
Gw&k Investment Management, Llc2025-03-31
344.4 K
Envestnet Asset Management Inc2025-03-31
316.5 K
Riverbridge Partners Llc2025-03-31
283.3 K
Northern Trust Corp2025-03-31
274.1 K
Rockefeller Capital Management L.p.2024-12-31
188.3 K
Point72 Asset Management, L.p.2025-03-31
180.7 K
Bank Of America Corp2025-03-31
171.6 K
Fmr Inc2025-03-31
163.8 K
Blackrock Inc2025-03-31
2.2 M
Vanguard Group Inc2025-03-31
1.1 M
Note, although US Physicalrapy's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

USPH Market Capitalization

The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.17 B.

USPH Profitablity

The company has Profit Margin (PM) of 0.05 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.08 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.08.
Last ReportedProjected for Next Year
Return On Tangible Assets 0.08  0.12 
Return On Capital Employed 0.06  0.06 
Return On Assets 0.02  0.02 
Return On Equity 0.05  0.08 

Management Efficiency

US Physicalrapy has return on total asset (ROA) of 0.0402 % which means that it generated a profit of $0.0402 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.0663 %, meaning that it created $0.0663 on every $100 dollars invested by stockholders. US Physicalrapy's management efficiency ratios could be used to measure how well US Physicalrapy manages its routine affairs as well as how well it operates its assets and liabilities. As of now, US Physicalrapy's Return On Tangible Assets are decreasing as compared to previous years. The US Physicalrapy's current Return On Equity is estimated to increase to 0.08, while Return On Capital Employed is projected to decrease to 0.06. As of now, US Physicalrapy's Non Currrent Assets Other are decreasing as compared to previous years. The US Physicalrapy's current Intangible Assets is estimated to increase to about 188.3 M, while Other Current Assets are projected to decrease to under 6.6 M.
Last ReportedProjected for Next Year
Book Value Per Share 50.39  52.91 
Tangible Book Value Per Share(5.80)(5.51)
Enterprise Value Over EBITDA 18.30  19.21 
Price Book Value Ratio 2.73  4.65 
Enterprise Value Multiple 18.30  19.21 
Price Fair Value 2.73  4.65 
Enterprise Value144.3 M151.5 M
Effective leadership at US Physicalrapy drives its competitive edge in the market. Our analysis focuses on how this translates to financial performance and stock value.
Dividend Yield
0.0234
Operating Margin
0.0828
Profit Margin
0.0481
Forward Dividend Yield
0.0234
Beta
1.445

Technical Drivers

As of the 16th of June 2025, US Physicalrapy owns the Downside Deviation of 1.66, mean deviation of 1.32, and Risk Adjusted Performance of 0.0234. Concerning fundamental indicators, the technical analysis model makes it possible for you to check potential technical drivers of US Physicalrapy, as well as the relationship between them.

US Physicalrapy Price Movement Analysis

Study
The minimum time period for execution of this function requires larger time horizon. Please increase the time horizon for this function. The output start index for this execution was zero with a total number of output elements of zero. The Instantaneous Trendline is a moving-average-like indicator which is formed by removing the Dominant Cycle from US Physicalrapy price series.

US Physicalrapy Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific US Physicalrapy insiders, such as employees or executives, is commonly permitted as long as it does not rely on US Physicalrapy's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases US Physicalrapy insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Christopher Reading over a week ago
Disposition of 10000 shares by Christopher Reading of US Physicalrapy at 90.01 subject to Rule 16b-3
 
Eric Williams over three weeks ago
Disposition of 633 shares by Eric Williams of US Physicalrapy at 78.09 subject to Rule 16b-3
 
Kathleen Gilmartin over three weeks ago
Acquisition by Kathleen Gilmartin of 1882 shares of US Physicalrapy subject to Rule 16b-3
 
Carey Hendrickson over two months ago
Disposition of tradable shares by Carey Hendrickson of US Physicalrapy subject to Rule 16b-3
 
Carey Hendrickson over three months ago
Disposition of tradable shares by Carey Hendrickson of US Physicalrapy subject to Rule 16b-3
 
Graham Reeve over three months ago
Disposition of 1730 shares by Graham Reeve of US Physicalrapy at 82.11 subject to Rule 16b-3
 
Graham Reeve over three months ago
Disposition of 1724 shares by Graham Reeve of US Physicalrapy at 105.46 subject to Rule 16b-3
 
Graham Reeve over three months ago
Acquisition by Graham Reeve of 8100 shares of US Physicalrapy subject to Rule 16b-3
 
Eric Williams over three months ago
Disposition of 2500 shares by Eric Williams of US Physicalrapy at 104.22 subject to Rule 16b-3
 
Bernard Harris over six months ago
Acquisition by Bernard Harris of 1600 shares of US Physicalrapy subject to Rule 16b-3
 
Richard Binstein over six months ago
Disposition of 1128 shares by Richard Binstein of US Physicalrapy at 98.52 subject to Rule 16b-3
 
Bernard Harris over six months ago
Disposition of 2000 shares by Bernard Harris of US Physicalrapy at 92.95 subject to Rule 16b-3

US Physicalrapy Outstanding Bonds

US Physicalrapy issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. US Physicalrapy uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most USPH bonds can be classified according to their maturity, which is the date when US Physicalrapy has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

US Physicalrapy Predictive Daily Indicators

US Physicalrapy intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of US Physicalrapy stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

US Physicalrapy Corporate Filings

F4
13th of June 2025
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
28th of May 2025
Other Reports
ViewVerify
F4
22nd of May 2025
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
F4
21st of May 2025
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
8K
20th of May 2025
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
14th of May 2025
Other Reports
ViewVerify
8K
13th of May 2025
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
10Q
9th of May 2025
Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations
ViewVerify

US Physicalrapy Forecast Models

US Physicalrapy's time-series forecasting models are one of many US Physicalrapy's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary US Physicalrapy's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About USPH Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how US Physicalrapy prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling USPH shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as US Physicalrapy. By using and applying USPH Stock analysis, traders can create a robust methodology for identifying USPH entry and exit points for their positions.
Last ReportedProjected for Next Year
Pretax Profit Margin 0.11  0.09 
Operating Profit Margin 0.11  0.07 
Net Profit Margin 0.05  0.05 
Gross Profit Margin 0.22  0.29 

Current USPH Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. USPH analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. USPH analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
106.0Strong Buy7Odds
US Physicalrapy current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most USPH analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand USPH stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of US Physicalrapy, talking to its executives and customers, or listening to USPH conference calls.
USPH Analyst Advice Details

USPH Stock Analysis Indicators

US Physicalrapy stock analysis indicators help investors evaluate how US Physicalrapy stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading US Physicalrapy shares will generate the highest return on investment. By understating and applying US Physicalrapy stock analysis, traders can identify US Physicalrapy position entry and exit signals to maximize returns.
Begin Period Cash Flow152.8 M
Long Term Debt142.5 M
Common Stock Shares Outstanding15.1 M
Total Stockholder Equity488.9 M
Tax Provision14.6 M
Quarterly Earnings Growth Y O Y0.716
Property Plant And Equipment Net166.1 M
Cash And Short Term Investments41.4 M
Cash41.4 M
Accounts Payable5.9 M
Net Debt253.9 M
50 Day M A73.1288
Total Current Liabilities116.3 M
Other Operating Expenses497.3 M
Non Current Assets TotalB
Forward Price Earnings31.8471
Non Currrent Assets Other5.2 M
Stock Based Compensation7.8 M

Complementary Tools for USPH Stock analysis

When running US Physicalrapy's price analysis, check to measure US Physicalrapy's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy US Physicalrapy is operating at the current time. Most of US Physicalrapy's value examination focuses on studying past and present price action to predict the probability of US Physicalrapy's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move US Physicalrapy's price. Additionally, you may evaluate how the addition of US Physicalrapy to your portfolios can decrease your overall portfolio volatility.
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world